Skip to main content
    The obesity clinic
    Menu closed
    Wegovy
    Ozempic
    Semaglutide
    +2

    Published 7 January 2026 · 7 minutes reading time

    Wegovy vs Ozempic - doctor explained

    Both contain semaglutide, but only one is approved for weight treatment. Learn the differences and why Wegovy is prescribed for weight loss.

    Wegovy vs Ozempic - comparison of semaglutide medications

    Quick answer

    Wegovy and Ozempic both contain semaglutide, but Wegovy is approved for obesity with a higher maximum dose. Ozempic is approved for type 2 diabetes and should be reserved for that indication.

    DD

    Dr. Dorél Lehrer

    Licensed Physician

    Medical Director at Viktenheten
    Experienced in medical weight management

    Verifierad av Socialstyrelsen

    Medicinskt granskad: 7 January 2026

    Wegovy and Ozempic share the same active ingredient, but they are approved for different indications and doses.

    Indications and dosing

    Ozempic is approved for type 2 diabetes up to 2 mg weekly. Wegovy is approved for obesity with a higher dose up to 2.4 mg.

    Why we prescribe Wegovy for weight loss

    Wegovy is the medically appropriate option for obesity, and it avoids off-label Ozempic use that can affect diabetes supply.

    Denna artikel är medicinsk information skriven av Dr. Dorél Lehrer, Licensed Physician. Eventuell behandling sker efter individuell bedömning av legitimerad läkare.

    Related Articles

    View all articles
    7 January 2026

    Mounjaro vs Wegovy - which is right for you?

    Read article
    5 February 2025

    GLP-1 Side Effects: What Research Shows

    Read article
    10 January 2025

    What is GLP-1 Treatment? A Doctor's Explanation

    Read article

    Discover more

    Part of Curevo Health

    Viktenheten is part of Curevo Health, Sweden’s digital specialist care platform.